Vaccine trial gets underway
The first clinical trial of the novel coronavirus vaccine in China has begun, and photos and videos of volunteers taking part in the project began to circulate on social media over the weekend.
The phase 1 clinical trial for recombinant novel coronavirus vaccine was registered on March 17, according to the Chinese Clinical Trial Registry. The COVID-19 vaccine was jointly developed by the Institute of Biotechnology, the Academy of Military Medical Sciences of the People's Liberation Army, and Tianjin-based CanSino Biologics Inc.
The trial is being conducted on 108 healthy adults ages 18 to 60 in two medical facilities in Wuhan, Hubei province.
The trial is expected to be completed by Dec 31, according to the registry.
As a subunit vaccine, it contains only a fragment of the pathogen to stimulate a protective immune response.
The volunteers will receive a series of follow-up examinations in the six months after being injected to see if their bodies have generated an antibody to the virus.